RadNet, Inc. (RDNT) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
RDNT currently has 77.1M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 5.83% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 11, 2026 |
10-Q filing | 77.1M shares outstanding |
77M | 0 |
| Jan 30, 2026 |
8-K filing: RadNet, Inc. filed a prospectus supplement to register for resale of up to 190,924 shares of common stock by the Cimar Sellers, as consideration for the acquisition of Cimar (UK) Limited. |
77M | 0 |
| Nov 10, 2025 |
10-Q filing | 77.4M shares outstanding |
77M | 0 |
| Oct 21, 2025 |
8-K filing: RadNet, Inc. filed a prospectus supplement to register for resale of up to 59,444 shares of the Company's common stock by selling stockholders. |
76M | 0 |
| Aug 11, 2025 |
10-Q filing | 75.5M shares outstanding |
76M | 0 |
| May 12, 2025 |
10-Q filing | 74.4M shares outstanding |
74M | 0 |
| Mar 03, 2025 |
10-K filing | 74.8M shares outstanding |
75M | 0 |
| Nov 12, 2024 |
10-Q filing | 73.5M shares outstanding |
73M | 0 |
| Aug 09, 2024 |
10-Q filing | 73.4M shares outstanding |
73M | 0 |
| May 10, 2024 |
10-Q filing | 69.3M shares outstanding |
69M | 0 |
| Mar 12, 2024 |
8-K filing: RadNet, Inc. completed an offering of 5,232,500 shares of common stock at $44.00 per share, resulting in gross proceeds of approximately $230.2 million, with net proceeds of approximately $218.2 million to be used for general corporate purposes and future acquisitions. ($230.2M proceeds) |
65M | 0 |
| Feb 29, 2024 |
10-K filing | 64.7M shares outstanding |
65M | 0 |
| Nov 09, 2023 |
10-Q filing | 67.8M shares outstanding |
68M | 0 |
| Aug 09, 2023 |
10-Q filing | 67.8M shares outstanding |
68M | 0 |
| Jun 16, 2023 |
8-K filing: RadNet, Inc. closed a public offering on June 16, 2023, selling 8,711,250 shares of common stock at $29.75 per share, resulting in gross proceeds of approximately $259.2 million, which will be used to repay $100 million of first lien term loans and for working capital. ($259.2M proceeds) |
58M | 0 |
| May 10, 2023 |
10-Q filing | 57.7M shares outstanding |
58M | 0 |
| Mar 01, 2023 |
10-K filing | 57.3M shares outstanding |
57M | 0 |
| Nov 09, 2022 |
10-Q filing | 57.7M shares outstanding |
58M | 0 |
| Aug 09, 2022 |
10-Q filing | 57.0M shares outstanding |
57M | 0 |
| May 10, 2022 |
10-Q filing | 56.4M shares outstanding |
56M | 0 |
| Mar 01, 2022 |
10-K filing | 53.4M shares outstanding |
53M | 0 |
| Jan 24, 2022 |
8-K filing: RadNet, Inc. consummated the acquisition of Aidence Holding B.V. and Quantib B.V., issuing 1,141,234 and 965,058 shares of RadNet, Inc. common stock to the stakeholders of Aidence and Quantib, respectively, in unregistered transactions. |
54M | 0 |
| Nov 09, 2021 |
10-Q filing | 53.8M shares outstanding |
54M | 0 |
| Aug 09, 2021 |
10-Q filing | 53.1M shares outstanding |
53M | 0 |
| May 10, 2021 |
10-Q filing | 52.8M shares outstanding |
53M | 0 |
| Mar 16, 2021 |
10-K filing | 50.9M shares outstanding |
51M | 0 |
| Dec 22, 2020 |
8-K filing: Norman Richard Hames, President and COO of RadNet, adopted a Rule 10b5-1 sales plan to sell up to 140,000 shares of RadNet Common Stock between February 17, 2021, and February 17, 2022. |
51M | 0 |
| Nov 09, 2020 |
10-Q filing | 51.4M shares outstanding |
51M | 0 |
| Aug 10, 2020 |
10-Q filing | 50.7M shares outstanding |
51M | 0 |
| May 11, 2020 |
10-Q filing | 50.3M shares outstanding |
50M | 0 |
| Mar 16, 2020 |
10-K filing | 49.7M shares outstanding |
50M | 0 |
| Mar 13, 2020 |
8-K filing: RadNet entered into an agreement to acquire DeepHealth, Inc. and will issue up to 1,000,000 shares of RadNet common stock at closing and up to an additional 1,500,000 shares of common stock upon DeepHealth's achievement of certain performance milestones. |
N/A | 0 |